These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12850277

  • 1. Non-covalent interaction of ubiquitin with insulin-degrading enzyme.
    Saric T, Müller D, Seitz HJ, Pavelic K.
    Mol Cell Endocrinol; 2003 Jun 30; 204(1-2):11-20. PubMed ID: 12850277
    [Abstract] [Full Text] [Related]

  • 2. Involvement of insulin-degrading enzyme in insulin- and atrial natriuretic peptide-sensitive internalization of amyloid-β peptide in mouse brain capillary endothelial cells.
    Ito S, Ohtsuki S, Murata S, Katsukura Y, Suzuki H, Funaki M, Tachikawa M, Terasaki T.
    J Alzheimers Dis; 2014 Jun 30; 38(1):185-200. PubMed ID: 23948938
    [Abstract] [Full Text] [Related]

  • 3. How the binding and degrading capabilities of insulin degrading enzyme are affected by ubiquitin.
    Grasso G, Rizzarelli E, Spoto G.
    Biochim Biophys Acta; 2008 Jun 30; 1784(7-8):1122-6. PubMed ID: 18489915
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Insulin-degrading enzyme is capable of degrading receptor-bound insulin.
    Yonezawa K, Yokono K, Shii K, Hari J, Yaso S, Amano K, Sakamoto T, Kawase Y, Akiyama H, Nagata M.
    Biochem Biophys Res Commun; 1988 Jan 29; 150(2):605-14. PubMed ID: 3277630
    [Abstract] [Full Text] [Related]

  • 7. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM, Bennett RG, Siford GL, Hamel FG.
    Biochem Pharmacol; 2009 Mar 15; 77(6):1064-73. PubMed ID: 19154729
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme.
    Müller D, Baumeister H, Buck F, Richter D.
    Eur J Biochem; 1991 Dec 05; 202(2):285-92. PubMed ID: 1836994
    [Abstract] [Full Text] [Related]

  • 10. Ubiquitin is a novel substrate for human insulin-degrading enzyme.
    Ralat LA, Kalas V, Zheng Z, Goldman RD, Sosnick TR, Tang WJ.
    J Mol Biol; 2011 Feb 25; 406(3):454-66. PubMed ID: 21185309
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex.
    Bennett RG, Hamel FG, Duckworth WC.
    Diabetes; 1997 Feb 25; 46(2):197-203. PubMed ID: 9000694
    [Abstract] [Full Text] [Related]

  • 12. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S.
    Proc Natl Acad Sci U S A; 2003 Apr 01; 100(7):4162-7. PubMed ID: 12634421
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Insulin-degrading enzyme is activated by the C-terminus of α-synuclein.
    Sharma SK, Chorell E, Wittung-Stafshede P.
    Biochem Biophys Res Commun; 2015 Oct 16; 466(2):192-5. PubMed ID: 26343304
    [Abstract] [Full Text] [Related]

  • 16. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
    Duckworth WC, Bennett RG, Hamel FG.
    Biochem Biophys Res Commun; 1998 Mar 17; 244(2):390-4. PubMed ID: 9514933
    [Abstract] [Full Text] [Related]

  • 17. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.
    Maianti JP, McFedries A, Foda ZH, Kleiner RE, Du XQ, Leissring MA, Tang WJ, Charron MJ, Seeliger MA, Saghatelian A, Liu DR.
    Nature; 2014 Jul 03; 511(7507):94-8. PubMed ID: 24847884
    [Abstract] [Full Text] [Related]

  • 18. Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin.
    Leissring MA, Malito E, Hedouin S, Reinstatler L, Sahara T, Abdul-Hay SO, Choudhry S, Maharvi GM, Fauq AH, Huzarska M, May PS, Choi S, Logan TP, Turk BE, Cantley LC, Manolopoulou M, Tang WJ, Stein RL, Cuny GD, Selkoe DJ.
    PLoS One; 2010 May 07; 5(5):e10504. PubMed ID: 20498699
    [Abstract] [Full Text] [Related]

  • 19. Degradation of relaxin family peptides by insulin-degrading enzyme.
    Bennett RG, Heimann DG, Hamel FG.
    Ann N Y Acad Sci; 2009 Apr 07; 1160():38-41. PubMed ID: 19416156
    [Abstract] [Full Text] [Related]

  • 20. Affinity purification of insulin-degrading enzyme and its endogenous inhibitor from rat liver.
    Ogawa W, Shii K, Yonezawa K, Baba S, Yokono K.
    J Biol Chem; 1992 Jan 15; 267(2):1310-6. PubMed ID: 1730651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.